skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0

Summary

Query: Party Name contains all words: GLAXO GROUP LIMITED
Number of results: 176+
Results are in reverse chronological order

Page #7. Previous 1 2 3 4 5 6 8 Next
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
85338823
11/10/2011
Glaxo Group Limited
Mark: TEXPRA S#:85338823
Novartis AG
85091360
10/17/2011
Glaxo Group Limited
Mark: SOLINAZ S#:85091360
Merck Sharp & Dohme Corp.
91201813
09/28/2011
Glaxo Group Limited
Mark: JUETRA S#:85228434
ThromboGenics NV
Mark: JETREA S#:79098752
85286729
09/14/2011
Glaxo Group Limited
Mark: JERTEXX S#:85286729
Vertex Pharmaceutical Incorporated
91201244
08/17/2011
Glaxo Group Limited
Mark: VOLUVAIR S#:85248394
Fresenius SE & Co. KGaA
85248394
07/27/2011
Glaxo Group Limited
Mark: VOLUVAIR S#:85248394
Fresenius SE
85248298
07/26/2011
Glaxo Group Limited
Mark: VELKEMI S#:85248298
Millennium Pharmaceuticals, Inc.
Actelion Pharmaceuticals Ltd.
79089028
07/20/2011
Relevare Aust. Pty Ltd
Mark: RELEVARE PHARMACEUTICALS S#:79089028
Glaxo Group Limited
79089313
07/20/2011
Relevare Aust. Pty Ltd
Mark: RELEVARE S#:79089313
Glaxo Group Limited
85067461
07/07/2011
Norbrook Laboratories Limited
Mark: CEFTIO S#:85067461
Glaxo Group Limited
85222114
06/30/2011
Glaxo Group Limited
Mark: LEFICEL S#:85222114
Johnson & Johnson
85226652
06/29/2011
Glaxo Group Limited
Mark: MOLOTREX S#:85226652
ACM
85228434
06/27/2011
Glaxo Group Limited
Mark: JUETRA S#:85228434
ThromboGenics NV
85209898
05/26/2011
Glaxo Group Limited
Mark: ZONITOR S#:85209898
Eisai Inc.
91199996
05/26/2011
Glaxo Group Limited
Mark: XANDU S#:85209901
Emami Limited
Mark: ZANDU --Emami is the owner and user (by assignment or otherwise) of the common law trademark ZANDU for goods in, inter alia, International Class 05, and has been continuously using ZANDU since 1999 in U.S. commerce.
85209904
05/26/2024
Glaxo Group Limited
Mark: TIAVO S#:85209904
Eli Lilly and Company
85182488
05/05/2011
Glaxo Group Limited
Mark: ZARJENT S#:85182488
Schering Corporation
85182427
04/29/2011
Glaxo Group Limited
Mark: GLASARI S#:85182427
Kamada Ltd.
85127903
03/18/2011
Glaxo Group Limited
Mark: BAZACTA S#:85127903
Bristol-Myers Squibb Company
Coloplast A/S
91198543
02/09/2011
Glaxo Group Limited
Mark: PERLENKO S#:85009771
H. A. North American Sales AB
Mark: PERLANE S#:78976443 R#:3030752
Mark: PERLANE-L S#:77940013 R#:3845221
91198542
02/09/2011
Glaxo Group Limited
Mark: PERLENRO S#:85009773
H. A. North American Sales AB
Mark: PERLANE S#:78976443 R#:3030752
Mark: PERLANE-L S#:77940013 R#:3845221
85090510
01/11/2011
Glaxo Group Limited
Mark: ELETAIR S#:85090510
Gilead Colorado, Inc.
85051727
11/29/2010
Glaxo Group Limited
Mark: VABRIC S#:85051727
Virbac
85009771
11/18/2010
Glaxo Group Limited
Mark: PERLENKO S#:85009771
H. A. North American Sales AB
77918265
11/17/2010
Glaxo Group Limited
Mark: FLOVIDA S#:77918265
Oriel Therapeutics, Inc.
Page #7. Previous 1 2 3 4 5 6 8 Next

Results as of 12/22/2024 12:40 AMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY